BioLineRx (BLRX) Enterprise Value Growth (5y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.98% |
| Sep 30, 2025 | -5.19% |
| Jun 30, 2025 | -3.01% |
| Mar 31, 2025 | -4.48% |
| Dec 31, 2024 | 6.58% |
| Sep 30, 2024 | 0.65% |
| Jun 30, 2024 | 0.31% |
| Mar 31, 2024 | 7.05% |
| Dec 31, 2023 | -7.35% |
| Sep 30, 2023 | 5.80% |
| Jun 30, 2023 | 3.82% |
| Mar 31, 2023 | 0.42% |
| Dec 31, 2022 | -0.64% |
| Sep 30, 2022 | -0.77% |
| Jun 30, 2022 | 4.33% |
| Mar 31, 2022 | -10.75% |
| Dec 31, 2021 | -9.91% |
| Sep 30, 2021 | -10.79% |
| Jun 30, 2021 | -9.41% |
| Mar 31, 2021 | -5.23% |
| Dec 31, 2020 | 13.87% |
| Sep 30, 2020 | 17.34% |
| Jun 30, 2020 | 13.15% |
| Mar 31, 2020 | 18.10% |
| Dec 31, 2019 | 4.54% |
| Sep 30, 2019 | -0.37% |
| Jun 30, 2019 | -1.23% |
| Mar 31, 2019 | -1.61% |
| Dec 31, 2018 | -10.60% |
| Sep 30, 2018 | -11.56% |
| Jun 30, 2018 | -11.88% |
| Mar 31, 2018 | -9.50% |
| Dec 31, 2017 | -32.92% |